Oncternal Therapeutics to Participate in March Investor Conferences


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


- H.C. Wainwright: Global Life Sciences Conference -
March 9th – 10th

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

- Oppenheimer 31st Annual Healthcare Conference -
March 16th – 17th

SAN DIEGO, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that management will participate in the following conferences in the month of March and invites investors to join by webcast. Please see details below:

H.C. Wainwright: Global Life Sciences Conference (Virtual)
Title:Oncternal Therapeutics (ONCT) Company Presentation
Date:Tuesday, March 9th, 2021
Time:On demand, starting at 7:00 am Eastern Time
Presenter:James Breitmeyer, President & CEO
Webcasting Link:Here


Oppenheimer 31st Annual Healthcare Conference (Virtual)
Title:Oncternal Therapeutics (ONCT) Company Presentation
Date:Tuesday, March 16th, 2021
Time:4:30 pm Eastern Time
Presenter:James Breitmeyer, President & CEO
Webcasting Link: Here

Webcasting Links:
Links to the webcasts along with replays will be accessible on the Events & Presentations page of the Investors section on the Company's website at https://investor.oncternal.com/news-and-events/events-presentations.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


About Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation or progression. The clinical pipeline includes cirmtuzumab, an investigational monoclonal antibody designed to inhibit the ROR1 pathway, a type I tyrosine kinase-like orphan receptor, that is being evaluated in a Phase 1/2 clinical trial in combination with ibrutinib for the treatment of patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) and in an investigator-sponsored, Phase 1b clinical trial in combination with paclitaxel for the treatment of women with HER2-negative metastatic or locally advanced, unresectable breast cancer. The clinical pipeline also includes TK216, an investigational targeted small-molecule inhibitor of the ETS family of oncoproteins, that is being evaluated in a Phase 1 clinical trial for patients with Ewing sarcoma alone and in combination with vincristine chemotherapy. In addition, Oncternal has a program utilizing the cirmtuzumab antibody backbone to develop a CAR-T therapy that targets ROR1, which is currently in preclinical development as a potential treatment for hematologic cancers and solid tumors. More information is available at www.oncternal.com.

Oncternal Contacts:

Company Contact
Richard Vincent
858-434-1113
rvincent@oncternal.com

Investor Contact
Corey Davis, Ph.D.               
LifeSci Advisors    
212-915-2577                      
cdavis@lifesciadvisors.com

Source: Oncternal Therapeutics, Inc.



Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsHealth CarePress Releases